课题基金 / 基金详情

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
批准号:
493526
负责人:
Grandi Sonia
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-09-01 至 2024-09-01

项目摘要

项目成果

Grandi Sonia的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In Canada, the use of new biologic medications, drugs that target specific processes in the body, has been steadily rising over the last ten years. This has been mainly due to their increased effectiveness and mild side effect profile for treating chronic
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aspirin and severe maternal morbidity and mortality and adverse pregnancy outcomes
  • 批准号:
    469014
  • 项目类别:
    Operating Grants
  • 资助金额:
    $21.46万
  • 财政年份:
    2022
  • 负责人:
    Grandi Sonia
  • 依托单位:
Population-Level Effects of Pregnancy Complications on Maternal and Offspring Mortality
  • 批准号:
    397050
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $10.93万
  • 财政年份:
    2018
  • 负责人:
    Grandi Sonia
  • 依托单位:
A Population-Based Analysis of the Trends in Treatment and Management of Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
海外基金